Tasly Pharmaceutical Group Co., Ltd. (600535)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
15. 63
-0.09
-0.5725%
¥
21.87B Market Cap
- P/E Ratio
1.04% Div Yield
20.77M Volume
- Eps
¥ 15.72
Previous Close Want to track 600535 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
600535 trading today lower at ¥15.63, a decrease of -0.5725% from yesterday's close, completing a monthly increase of 18.0514% or ¥2.39. Over the past 12 months, 600535 stock gained 3.5785%.
600535 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 3 months on Nov 29, 2026 for a total of ¥0.1.
The last earnings report, released on Apr 28, 2026, missed the consensus estimates by -0.21%. On average, the company has fell short of earnings expectations by -0.12%, based on the last three reports.
Tasly Pharmaceutical Group Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 05, 2018.
The company's stock is traded on one exchange.
600535 Chart
People also search for
Tasly Pharmaceutical Group Co., Ltd. (600535) FAQ
What is the stock price today?
The current price is ¥15.63.
On which exchange is it traded?
Tasly Pharmaceutical Group Co., Ltd. is listed on SSE.
What is its stock symbol?
The ticker symbol is 600535.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.04%.
What is its market cap?
As of today, the market cap is 21.87B.
Has Tasly Pharmaceutical Group Co., Ltd. ever had a stock split?
Tasly Pharmaceutical Group Co., Ltd. had 5 splits and the recent split was on Jun 05, 2018.
Tasly Pharmaceutical Group Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Jing Su CEO | SSE Exchange | CNE000001C81 ISIN |
| CN Country | - Employees | 29 May 2026 Last Dividend | 5 Jun 2018 Last Split | 8 Aug 2002 IPO Date |
Overview
Tasly Pharmaceutical Group Co., Ltd is a prominent entity in the pharmaceutical sector that operates both within China and on an international scale. The company has been active since its foundation in 1994, with its headquarters located in Tianjin, China. Tasly Pharmaceutical Group Co., Ltd is recognized for its diversified portfolio in the pharmaceutical industry, focusing on providing innovative health solutions across various therapeutic areas. Their mission revolves around addressing some of the most pressing health issues faced by patients worldwide, by delivering products that ensure quality, safety, and efficacy.
Products and Services
Tasly Pharmaceutical Group Co., Ltd offers a wide range of products and services designed to cater to the health needs of patients. These include:
- Cardiovascular Solutions: Tasly is well-known for its comprehensive range of products aimed at managing and treating cardiovascular diseases. These products are designed to improve heart health and patient quality of life, with a focus on innovation and clinical efficacy.
- Anti-tumor: The company provides a variety of anti-tumor medications aimed at combating different forms of cancer. By investing in research and development, Tasly aims to deliver effective solutions that can help in the fight against cancer, offering hope and improved outcomes for patients.
- Cold and Fever Remedies: Recognizing the commonality and discomfort of colds and fevers, Tasly offers a selection of treatments to alleviate symptoms and promote faster recovery. These products are formulated based on extensive research to ensure their safety and effectiveness.
- Liver Disease Treatments: With liver health being crucial for overall well-being, Tasly provides treatments specifically targeted at managing and curing various liver diseases. These products are the result of innovative research aimed at enhancing liver function and patient health.
- Other Disease Solutions: Beyond these specific areas, Tasly Pharmaceutical Group Co., Ltd also addresses a broader spectrum of health conditions through a variety of other products and services. This diverse offering ensures that the company can meet the wide-ranging needs of patients, contributing to their better health and well-being.
Contact Information
Address: 2 Pujihe East Road, Tianjin, China, 300410
Phone: 86 22 2673 6999
Website: https://www.taslypharma.com
